EMAPALUMAB-LZSG

EMAPALUMAB-LZSG was reported 237 times

EMAPALUMAB-LZSG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LYSINURIC PROTEIN INTOLERANCE 1 0.5000
1 INTERFERON GAMMA DECREASED 1 0.1111
2 NATURAL KILLER T CELL COUNT INCREASED 1 0.0909
3 ERYTHROBLASTOSIS 2 0.0400
4 CHEMOKINE INCREASED 1 0.0370
5 FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0323
6 ABNORMAL ORGAN GROWTH 1 0.0227
7 CYTOKINE ABNORMAL 1 0.0192
8 BLOOD FIBRINOGEN ABNORMAL 1 0.0175
9 HYPERRESPONSIVE TO STIMULI 1 0.0159
10 HEPATOBLASTOMA 1 0.0103
11 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 72 0.0096
12 AUTOINFLAMMATORY DISEASE 2 0.0094
13 NUCLEATED RED CELLS 1 0.0089
14 ALVEOLAR PROTEINOSIS 5 0.0084
15 HYPERFERRITINAEMIA 3 0.0070
16 SERUM FERRITIN ABNORMAL 2 0.0063
17 CYTOMEGALOVIRUS SYNDROME 1 0.0061
18 GLYCOSURIA 8 0.0059
19 MEASLES 3 0.0056
20 GRANULOCYTOSIS 1 0.0051
21 CD4 LYMPHOCYTES ABNORMAL 1 0.0048
22 BONE MARROW TRANSPLANT REJECTION 1 0.0045
23 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0045
24 ADENOVIRUS INFECTION 13 0.0045
25 HUMAN HERPESVIRUS 6 ENCEPHALITIS 1 0.0035
26 STREPTOCOCCAL SEPSIS 4 0.0034
27 TEETHING 1 0.0033
28 HYPOFIBRINOGENAEMIA 3 0.0030
29 ENTEROCOCCAL BACTERAEMIA 3 0.0028
30 HERPES ZOSTER MENINGOENCEPHALITIS 1 0.0028
31 PRODUCT SELECTION ERROR 3 0.0027
32 ANISOCORIA 1 0.0026
33 T-CELL LYMPHOMA 3 0.0026
34 BLOOD FIBRINOGEN INCREASED 2 0.0025
35 ENTEROBACTER INFECTION 4 0.0024
36 SERUM FERRITIN INCREASED 12 0.0023
37 EPSTEIN-BARR VIRUS INFECTION 14 0.0022
38 PNEUMONIA CYTOMEGALOVIRAL 4 0.0021
39 EPIGLOTTITIS 1 0.0018
40 INTERLEUKIN LEVEL INCREASED 1 0.0018
41 SERUM FERRITIN DECREASED 3 0.0017
42 MONOCYTE COUNT DECREASED 2 0.0016
43 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
44 VIRAEMIA 2 0.0014
45 ESCHERICHIA SEPSIS 4 0.0014
46 BRAIN DEATH 4 0.0013
47 HERPES ZOSTER DISSEMINATED 1 0.0012
48 BACTERIAL SEPSIS 4 0.0012
49 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
50 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
51 BLOOD IMMUNOGLOBULIN M DECREASED 1 0.0010
52 VARICELLA ZOSTER VIRUS INFECTION 2 0.0010
53 NON-CARDIOGENIC PULMONARY OEDEMA 1 0.0009
54 CATHETER SITE DISCHARGE 1 0.0009
55 DISTRIBUTIVE SHOCK 2 0.0009
56 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 5 0.0008
57 FULL BLOOD COUNT INCREASED 1 0.0008
58 HYPERNATRAEMIA 4 0.0008
59 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
60 VIRAL LOAD INCREASED 3 0.0008
61 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 1 0.0008
62 MYOPATHY 6 0.0007
63 BRAIN HERNIATION 2 0.0007
64 STEROID DIABETES 1 0.0007
65 HAEMODYNAMIC INSTABILITY 5 0.0007
66 LOSS OF THERAPEUTIC RESPONSE 2 0.0006
67 SPLENIC RUPTURE 1 0.0006
68 PUPIL FIXED 1 0.0006
69 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1 0.0006
70 HAEMORRHAGIC DIATHESIS 2 0.0006
71 HYPERTRIGLYCERIDAEMIA 3 0.0005
72 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
73 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14 0.0005
74 SEPTIC SHOCK 21 0.0005
75 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
76 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
77 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
78 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
79 IMPLANT SITE INFECTION 1 0.0004
80 ESCHERICHIA BACTERAEMIA 1 0.0004
81 GRAFT VERSUS HOST DISEASE 3 0.0004
82 ENTEROCOCCAL INFECTION 2 0.0004
83 CYTOPENIA 5 0.0004
84 STAPHYLOCOCCAL SEPSIS 2 0.0004
85 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
86 SYSTEMIC CANDIDA 1 0.0004
87 PLATELET DISORDER 1 0.0004
88 DERMATOMYOSITIS 1 0.0004
89 MEAN CELL VOLUME INCREASED 1 0.0004
90 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
91 LYMPHOPROLIFERATIVE DISORDER 1 0.0003
92 PULMONARY HYPERTENSION 7 0.0003
93 EMBOLISM VENOUS 1 0.0003
94 HEPATIC CIRRHOSIS 6 0.0003
95 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
96 SUSPECTED COVID-19 1 0.0003
97 HYPERBILIRUBINAEMIA 3 0.0003
98 FIBRIN D DIMER INCREASED 1 0.0003
99 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
100 NERVOUS SYSTEM DISORDER 8 0.0003
101 HAEMORRHAGIC STROKE 2 0.0003
102 PNEUMONIA FUNGAL 1 0.0003
103 BACTERAEMIA 3 0.0003
104 ORGAN FAILURE 1 0.0002
105 GASTROINTESTINAL PERFORATION 1 0.0002
106 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
107 SUSPECTED OFF LABEL USE 1 0.0002
108 HYPERGLYCAEMIA 8 0.0002
109 DISEASE COMPLICATION 1 0.0002
110 CYTOKINE RELEASE SYNDROME 4 0.0002
111 KLEBSIELLA INFECTION 1 0.0002
112 CONDITION AGGRAVATED 60 0.0002
113 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1 0.0002
114 APLASTIC ANAEMIA 1 0.0002
115 COLITIS 7 0.0002
116 CYTOMEGALOVIRUS INFECTION 3 0.0002
117 HYPERTENSIVE CRISIS 2 0.0002
118 STREPTOCOCCAL INFECTION 1 0.0002
119 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
120 CANDIDA INFECTION 3 0.0002
121 LYMPHOCYTE COUNT DECREASED 3 0.0002
122 CHOLANGITIS 1 0.0002
123 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
124 HEPATITIS 4 0.0002
125 DRUG RESISTANCE 4 0.0002
126 HAEMOGLOBIN ABNORMAL 1 0.0002
127 HYPOGAMMAGLOBULINAEMIA 1 0.0002
128 IMMUNE SYSTEM DISORDER 2 0.0002
129 BONE MARROW FAILURE 3 0.0001
130 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
131 BODY TEMPERATURE INCREASED 3 0.0001
132 PRODUCT AVAILABILITY ISSUE 3 0.0001
133 DEVICE RELATED INFECTION 2 0.0001
134 PULMONARY HAEMORRHAGE 1 0.0001
135 RESPIRATORY FAILURE 9 0.0001
136 ENCEPHALOPATHY 3 0.0001
137 HAEMOLYTIC ANAEMIA 1 0.0001
138 PRODUCT DISTRIBUTION ISSUE 1 0.0001
139 OFF LABEL USE 94 0.0001
140 FULL BLOOD COUNT ABNORMAL 1 0.0001
141 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
142 DECREASED ACTIVITY 1 0.0001
143 INTESTINAL PERFORATION 1 0.0001
144 STATUS EPILEPTICUS 1 0.0001
145 SPLENOMEGALY 1 0.0001
146 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
147 SEPSIS 9 0.0001
148 HEPATIC CYTOLYSIS 1 0.0001
149 BEDRIDDEN 1 0.0001
150 SARS-COV-2 TEST POSITIVE 1 0.0001
151 OEDEMA 4 0.0001
152 TACHYPNOEA 1 0.0001
153 BLOOD TEST ABNORMAL 1 0.0001
154 SUBDURAL HAEMATOMA 1 0.0001
155 CARDIOGENIC SHOCK 1 0.0001
156 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
157 LIVER FUNCTION TEST ABNORMAL 2 0.0001
158 IMMUNODEFICIENCY 1 0.0001
159 HAEMORRHAGE INTRACRANIAL 1 0.0001
160 PLATELET COUNT DECREASED 7 0.0001
161 LYMPHOMA 1 0.0001
162 MUSCULOSKELETAL CHEST PAIN 1 0.0001
163 ACUTE MYELOID LEUKAEMIA 1 0.0001
164 THROMBOCYTOPENIA 7 0.0001
165 HYPERTENSION 13 0.0001
166 FUNGAL INFECTION 2 0.0001
167 FACE OEDEMA 1 0.0001
168 HYPOXIA 2 0.0001
169 PANCREATITIS 3 0.0001
170 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
171 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
172 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
173 PROTEINURIA 1 0.0001
174 PULMONARY FIBROSIS 1 0.0001
175 ACUTE RESPIRATORY FAILURE 1 0.0001
176 SEIZURE 6 0.0001
177 NEUTROPHIL COUNT DECREASED 2 0.0000
178 CARDIAC ARREST 4 0.0000
179 CARDIO-RESPIRATORY ARREST 2 0.0000
180 LIVER FUNCTION TEST INCREASED 1 0.0000
181 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
182 RASH MACULO-PAPULAR 1 0.0000
183 THERAPY NON-RESPONDER 2 0.0000
184 PANCREATITIS ACUTE 1 0.0000
185 CHILLS 5 0.0000
186 DISEASE PROGRESSION 5 0.0000
187 PRESYNCOPE 1 0.0000
188 HYPOTENSION 8 0.0000
189 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
190 PYREXIA 13 0.0000
191 RESPIRATORY DISTRESS 1 0.0000
192 HERPES ZOSTER 2 0.0000
193 LABORATORY TEST ABNORMAL 1 0.0000
194 DEATH 29 0.0000
195 IRRITABILITY 2 0.0000
196 HEPATIC FAILURE 1 0.0000
197 LIMB DISCOMFORT 1 0.0000
198 EXPOSURE DURING PREGNANCY 2 0.0000
199 LACTIC ACIDOSIS 1 0.0000
200 LIP SWELLING 1 0.0000
201 SKIN DISORDER 1 0.0000
202 HEPATIC ENZYME INCREASED 2 0.0000
203 HAEMOGLOBIN DECREASED 3 0.0000
204 LYMPHADENOPATHY 1 0.0000
205 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
206 INFECTION 4 0.0000
207 CRYING 1 0.0000
208 DYSURIA 1 0.0000
209 DRUG INEFFECTIVE 32 0.0000
210 TREATMENT FAILURE 2 0.0000
211 INTENTIONAL PRODUCT MISUSE 2 0.0000
212 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
213 PULMONARY OEDEMA 1 0.0000
214 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
215 HYPOKALAEMIA 1 0.0000
216 INFLAMMATION 1 0.0000
217 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
218 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
219 ANAPHYLACTIC REACTION 1 0.0000
220 PANCYTOPENIA 1 0.0000
221 BLISTER 1 0.0000
222 HYPONATRAEMIA 1 0.0000
223 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
224 ABDOMINAL PAIN 4 0.0000
225 PRODUCT DOSE OMISSION ISSUE 5 0.0000
226 CATARACT 1 0.0000
227 THERAPEUTIC RESPONSE DECREASED 1 0.0000
228 VERTIGO 1 0.0000
229 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
230 NEOPLASM MALIGNANT 1 0.0000
231 ARTHRITIS 1 0.0000
232 CARDIAC FAILURE CONGESTIVE 1 0.0000
233 CONFUSIONAL STATE 2 0.0000
234 TOXICITY TO VARIOUS AGENTS 2 0.0000
235 BALANCE DISORDER 1 0.0000
236 RASH 5 0.0000
237 TACHYCARDIA 1 0.0000
238 DEVICE ISSUE 1 0.0000
239 CHEST PAIN 2 0.0000
240 VOMITING 5 0.0000
241 PULMONARY EMBOLISM 1 0.0000
242 NEUROPATHY PERIPHERAL 1 0.0000
243 ANAEMIA 2 0.0000
244 FLUSHING 1 0.0000
245 ILLNESS 1 0.0000
246 INFLUENZA 1 0.0000
247 WEIGHT INCREASED 2 0.0000
248 FEELING ABNORMAL 2 0.0000
249 VISUAL IMPAIRMENT 1 0.0000
250 LOSS OF CONSCIOUSNESS 1 0.0000
251 HYPERHIDROSIS 1 0.0000
252 RENAL FAILURE 1 0.0000
253 NEUTROPENIA 1 0.0000
254 ACUTE KIDNEY INJURY 1 0.0000
255 PARAESTHESIA 1 0.0000
256 URINARY TRACT INFECTION 1 0.0000
257 COVID-19 1 0.0000
258 NO ADVERSE EVENT 1 0.0000
259 NAUSEA 4 0.0000
260 SOMNOLENCE 1 0.0000
261 CONSTIPATION 1 0.0000
262 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
263 PAIN IN EXTREMITY 1 0.0000
264 PNEUMONIA 1 0.0000
265 ARTHRALGIA 1 0.0000
266 MALAISE 1 0.0000
267 DYSPNOEA 1 0.0000
268 PAIN 1 0.0000
269 HEADACHE 1 0.0000